Evaluation of the Hematological Patterns from Up to 985 Days of Long COVID: A Cross-Sectional Study

Area of Science:

• Hematology
• Infectious Diseases
• Immunology

Background:

• Long COVID, a persistent condition following COVID-19, is associated with enduring hematological alterations.
• Understanding these post-acute COVID-19 hematological changes is crucial for managing long-term patient outcomes.

Purpose of the Study:

• To evaluate persistent hematological laboratory markers in long COVID patients.
• To correlate these markers with clinical findings and long-term outcomes.
• To investigate potential compensatory mechanisms and exacerbated responses in long COVID.

Main Methods:

• Cross-sectional study design.
• Participant recruitment from a long COVID clinical care program in the Amazon region.
• Collection of clinical data, demographics, and blood samples for erythrogram, leukogram, and plateletgram analysis.

Main Results:

• Patients hospitalized during acute COVID-19 showed higher red/white blood cell, platelet, and plateletcrit levels, and red blood cell distribution width.
• Hematimetric parameters were elevated in shorter durations of long COVID compared to longer durations.
• Patients with over six long COVID symptoms exhibited higher white blood cell counts, shorter prothrombin times, and increased prothrombin activity.

Conclusions:

• Evidence suggests a compensatory mechanism for erythrogram markers within 985 days of long COVID.
• Elevated leukogram markers and coagulation activity in severe long COVID groups indicate a potentially exacerbated response.
• Further investigation is needed to understand the implications of these hematological changes in long COVID.